fashion -WSS

fashion

author：hotspot 2025-09-27 16:47:45 - browse：9

A judge ruled that Welsh Carson won't have to face antitrust allegations about its anesthesiology practice. Adobe

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia Partners, still must face the agency’s antitrust case, a judge ruled last week.

The FTC alleged last year that the anesthesiology network monopolized markets in Texas to drive up prices, but took the unusual step of attaching Welsh Carson as a defendant with USAP. Dismissing Welsh Carson from the case was a victory for the private equity firm and, more broadly, other firms worried that the Biden administration would try to hold them responsible for anything their portfolio companies do.

But the allegations against USAP didn’t disappear, which will keep up scrutiny on companies that have made a push to acquire numerous physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： FDA reorg will put new emphasis on investigations, sources say

explore

hotspot

WSS

White House announces new plan to address the growing threat of xylazine in overdose crisis

White House drug czar issues call for 'recovery

Home health providers sue Medicare over payment cuts

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

leisure time

Activists slam private health insurers over coverage restrictions

Teachers share how revamped forgiveness program helped with their student loans

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Peter Hotez and the public health issue of online harassment

FDA reorg will put new emphasis on investigations, sources say

Novavax promises a turnaround & Lilly roils the obesity market

The U.S. needs a new definition of substance use “recovery”

The high cost of giving birth even with insurance

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

entertainment

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Pandemic and All Hazards Preparedness Act needs lean update

Create a giant ice tray with this foil pan hack to keep food cold this summer

Ohio still needs to do more to protect the right to abortion

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Type 2 diabetes prevention programs work at large scale: study

explore

entertainment

hotspot

hotspot